Cochrane Reviews: Tuberculosis

06 Sep 2022

Update: 'Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children'

This review update (original version published 27 August 2020) examines the evidence from the previous review in assessing the diagnostic accuracy of Xpert Ultra for detecting: pulmonary tuberculosis, tuberculous meningitis, lymph node tuberculosis, and rifampicin resistance, in children with presumed tuberculosis.

Cochrane Systematic Review: UPDATE

19 May 2022

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin

How accurate is Xpert MTB/XDR for detecting pulmonary tuberculosis and resistance to tuberculosis drugs (i.e. isoniazid, fluoroquinolones, ethionamide, and amikacin) in adults?

Cochrane Systematic Review: NEW

26 Apr 2022

Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views

This Cochrane Review summarizes research on recipient and provider views

Cochrane Systematic Review: NEW

23 Mar 2022

Symptom‐ and chest‐radiography screening for active pulmonary tuberculosis in HIV‐negative adults and adults with unknown HIV status

How accurate are asking about symptoms and doing a chest X‐ray to screen for tuberculosis of the lungs among adults who are HIV‐negative or with unknown HIV status?

Cochrane Systematic Review: NEW

READ-IT

Search

Cochrane Reviews: Tuberculosis

Update: 'Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children'

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin

Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views

Symptom‐ and chest‐radiography screening for active pulmonary tuberculosis in HIV‐negative adults and adults with unknown HIV status

Contact us

Follow us